## ORCL: Oracle Corporation - XLK: Technology

### Executive Summary

No thesis match: MRS_20 -10.9% below STRENGTH zone (4.0-10.0%); PEG 2.30 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($177.24)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Super Micro, Palantir, Oracle Crash In November Tech Stock Massacre - Super Micro Computer (NASDAQ:SMCI)**
- Source: Benzinga | 20251201T184500 | Neutral | Relevance: 100%
- November 2025 proved to be a challenging month for high-flying tech stocks, including Super Micro Computer, Palantir, and Oracle, which experienced significant drops in market capitalization. This decline was attributed to a broader market shift away from "AI hype" stocks into more defensive sectors, coupled with company-specific issues such as disappointing earnings and concerns over financial controls. Other notable tech companies like Arm Holdings, Arista Networks, and Coinbase Global also saw substantial declines.

**2. Dixon Mitchell Investment Counsel Inc. Acquires 2,363 Shares of Oracle Corporation $ORCL**
- Source: MarketBeat | 20251130T100644 | Somewhat-Bullish | Relevance: 99%
- Dixon Mitchell Investment Counsel Inc. increased its stake in Oracle Corporation by 3.8% in the second quarter, acquiring an additional 2,363 shares and bringing their total holdings to 64,864 shares valued at $14,324,000. Other institutional investors also adjusted their positions in Oracle, while Wall Street analysts have issued mixed ratings, with a consensus of "Moderate Buy" and an average price target of $324.89. The article also details Oracle's recent financial performance, dividend announcement, and insider trading activity.

**3. OMERS ADMINISTRATION Corp Sells 19,011 Shares of Oracle Corporation $ORCL**
- Source: MarketBeat | 20251201T124048 | Neutral | Relevance: 99%
- OMERS ADMINISTRATION Corp reduced its stake in Oracle Corporation by 12.5%, selling 19,011 shares and now holding 133,153 shares valued at approximately $29.11 million. This follows significant insider selling from CEO Clayton Magouyrk and Director Jeffrey Berg, totaling over $24 million, contributing to insiders offloading more than $60 million in stock. Oracle reported slightly missed earnings guidance but saw a 12.2% year-over-year revenue increase and carries a "Moderate Buy" consensus rating from analysts.

**4. Oracle Stock Slides to $201 as Debt and AI Jitters Collide With Strong Growth: ORCL Update for November 29, 2025**
- Source: ts2.tech | 20251129T043632 | Neutral | Relevance: 98%
- Oracle stock (ORCL) has declined to $201 amid concerns over its growing debt load, especially linked to a massive AI deal with OpenAI, despite strong double-digit cloud growth and a record AI backlog. The article details the market's polarized view, with some analysts seeing a buying opportunity after a significant price reset, while others caution about concentration risk and negative free cash flow. Upcoming Q2 2026 earnings on December 8, 2025, are anticipated to be a major catalyst for Oracle's future stock performance as investors seek clarity on funding strategies, cloud margins, and AI backlog diversification.

**5. Unusual Activity in Oracle Corp Put Options Highlights ORCL Stock's Value**
- Source: MSN | 20251201T085136 | Neutral | Relevance: 98%
- Unusual put option activity for Oracle Corp (ORCL) suggests that institutional investors are betting on a potential dip in the stock price as shares trade near their 52-week high. Despite this, Oracle's fundamentals, including strong revenue growth and a high return on equity, indicate it could still be undervalued, presenting a complex picture for investors.

### Analyst Activity

**Target Signal:** VERY_BEARISH (Raises: 0, Lowers: 4)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Barclays | $330 | $400 | -18% |
| 2025-12-04 | Citigroup | $375 | $415 | -10% |
| 2025-11-26 | Deutsche Bank | $375 | $375 | 0% |
| 2025-11-25 | DA Davidson | $200 | $300 | -33% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Barclays | main | Overweight |
| 2025-12-04 | Citigroup | main | Buy |
| 2025-11-26 | Deutsche Bank | reit | Buy |
| 2025-11-25 | DA Davidson | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 13 ($0.04M) |
| Sells | 24 ($76.91M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 21.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Vanguard Group Inc: 5.9% (+2.8%)
- Blackrock Inc.: 4.9% (+3.3%)
- JPMORGAN CHASE & CO: 3.5% (+117.2%)
- State Street Corpora: 2.6% (-0.2%)
- Geode Capital Manage: 1.3% (+2.1%)

### Key Risks

1. Heavy insider selling: $77M sold (24 transactions in 90 days).
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.30 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 69%, margin 21%). Revenue growth strong at 25% YoY. Analyst sentiment negative (4 target cuts vs 0 raises). Insider selling cluster ($76.9M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $635.8B |
| Beta | 1.66 |
| 52W Range | $118.86 - $345.72 |
| Short Interest | 1.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.30 |
| Forward P/E | 25.1 |
| Current P/E | 29.5 |
| YoY Growth | 17.3% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -14.3% to -10.9% (+3.4% in 5 days), confirming momentum buildup. Below STRENGTH zone by 14.9pp (needs >4.0% for momentum thesis). AM_20 at -10.0% indicates price below own 20MA trend. Underperforming sector by 9.8pp, stock-specific weakness. Below SMA200 (0.95x), long-term trend not supportive. MACD histogram bearish (-0.73), momentum weakening.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -10.87% (CS: 3) | Weak |
| RSI_14 | 30.3 | Neutral |
| MACD Histogram | -0.73 | Bearish |
| vs SMA20 | 0.900x | Below |
| vs SMA50 | 0.765x | Below |
| vs SMA200 | 0.951x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $200.94
- **Stop Loss:** $177.24 (11.8% risk)
- **Target:** $224.64 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 50
- **Position Value:** $10,047.00
- **Portfolio %:** 10.05%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.48 | $1.47 | -0.6% |
| 2025Q2 | $1.64 | $1.70 | +3.4% |
| 2025Q1 | $1.49 | $1.47 | -1.4% |
| 2024Q4 | $1.48 | $1.47 | -0.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*